# Chord Energy Corporation (CHRD) — Financial Analysis

**Exchange:** NASDAQ  
**Coverage as of:** 2026-Q2  
**Updated:** 2026-05-28  
**Tier:** Free primer (step 2 of 19)  
**Sibling pages:** /stocks/CHRD/thesis · /stocks/CHRD/memo

## Financial Snapshot

---
ticker: CHRD
step: 04
title: Financial Quality & Adversarial Sweep
source: coverage-next-full
created: 2026-05-28
---

### Step 04 — Financial Quality & Adversarial Sweep

#### Key Findings

- **GAAP earnings quality is mixed in 2024-2025** due to (a) Enerplus-acquisition bargain-purchase / step-up accounting boosting 2024 GAAP net income ($1,856M reported vs. underlying ~$900M-$1B), (b) $539M goodwill impairment depressing 2025 GAAP net income ($44.5M reported vs. adjusted ~$1.5-1.6B) [S1][S3].
- **Cash-flow quality is high** — operating cash flow $2.04B FY25 / $2.10B FY24 is clean and consistent; FCF (post-capex) ~$600M+ in FY25 at depressed WTI [S2][S3].
- **No identified material accounting concerns** beyond standard E&P sector noise (DD&A volatility, hedging mark-to-market, impairment cycles). NSAI-certified reserves provide third-party validation of the largest balance-sheet asset (PV-10 = $9.07B at SEC pricing) [S4].
- Adversarial sweep: **no active short reports, no investigations, no material litigation** outside ordinary-course E&P matters. DAPL litigation is industry-wide and not CHRD-specific.

#### Implications for Thesis and Valuation

- Use **adjusted earnings** for valuation multiples; back out goodwill impairment, bargain-purchase gains, and material hedging mark-to-market. The market clearly does this (consensus FY26E EPS $18.30 vs. trailing GAAP $1.03 in FY25).
- Cash-based metrics (OpCF, FCF, FCF yield) are the **highest-quality metrics for this name** and should be the spine of any valuation framework.
- No fraud-risk red flags, no accounting aggressiveness pattern, no governance overhang. The financial-quality story is **clean by E&P standards**.

#### Objective

Assess earnings quality, identify reconciling items between GAAP and economic reality, and run an adversarial research sweep for short reports, investigations, lawsuits, or other red flags.

#### Narrative Analysis

##### Earnings quality assessment

The headline GAAP earnings line is **structurally noisy for E&P companies generally** and especially for CHRD given the three-deals-in-four-years pattern. Two specific adjustments are necessary to read CHRD's earning power:

**1. 2024 GAAP net income overstated.** FY2024 GAAP net income of $1,856M [S2] materially exceeds the underlying earning power because of acquisition accounting under ASC 805 for the Enerplus deal — purchase-price allocation produced a bargain-purchase gain (or at minimum step-up of acquired assets affecting subsequent DD&A treatment) that flowed through GAAP net income. Adjusted/operating-cash earnings for FY24 were closer to ~$900M-$1B [S3]. Consensus and management presentations both use the adjusted figure.

**2. 2025 GAAP net income understated.** FY2025 GAAP net income of $44.5M [S2] is depressed by the **$539.3M Q2 2025 goodwill impairment** [S5] — a non-cash charge tied to the Enerplus-deal-created goodwill, triggered when CHRD's market cap declined and WTI weakened in mid-2025. The impairment is properly excluded for valuation purposes. Adjusted net income ~$1.5-1.6B is consistent with operating CF of $2.04B less D&A normalized capex.

##### Cash flow quality

Operating cash flow is the highest-quality metric in this name:

| FY | OpCF ($M) | YoY | Quality signal |
|---:|---:|---|---|
| 2022 | 914 | (Whiting partial year) | n/a clean comp |
| 2023 | 1,820 | +99% (first full year) | high |
| 2024 | 2,097 | +15% | high |
| 2025 | 2,041 | -3% (WTI down ~10%) | high — held up vs. price weakness |

The 2024 → 2025 modest decline despite WTI down ~10% YoY illustrates the **production-growth offset** from the Enerplus full-year inclusion. OpCF growth is positive on a per-share basis (despite share count rising from the merger) because share buybacks have offset some of the dilution [S2].

Working capital movements in cash flow are clean — no signs of receivable buildup or stretching payables to flatter OpCF.

##### DD&A volatility

DD&A swings from $158M (FY22 short stub) to $370M (FY24) to $599M (FY25) [S2] — the swings are explained by acquisition accounting (acquired PP&E depreciates from acquisition date forward) plus production volume growth. **No quality concern** — these movements are mechanically explained by the M&A timeline.

##### Reserves disclosure quality

CHRD uses **Netherland, Sewell & Associates (NSAI)** as independent reserve engineer [S4]. NSAI is a top-tier independent firm. FY25 proved reserves of 917.5 MMBoe at PV-10 $9.07B (SEC pricing $65.34 WTI / $3.39 HH) is a solid third-party validation of the largest balance-sheet asset. PV-10 exceeds book value of PP&E ($10.7B gross / ~$8B-ish net) implying real-world reserves value is in the same ballpark as carrying value, with upside at strip pricing meaningfully higher.

##### Adversarial Research Sweep

| Item | Status | Notes |
|---|---|---|
| Active short reports (Hindenburg, Muddy Waters, etc.) | **None identified** | No prominent short-seller report on CHRD in last 24 months |
| SEC investigation / enforcement | **None identified** | No 8-K disclosures of SEC inquiry; no Wells Notice |
| DOJ / FBI investigation | **None identified** | — |
| Securities class action lawsuit | **None of material magnitude** | Standard E&P ordinary-course litigation; no significant class-action filing identified |
| Whistleblower allegations | **None identified** | — |
| Auditor changes / qualified opinions | **No** | Standard unqualified opinion FY25 |
| DAPL litigation | **Industry-wide overhang, not company-specific** | The Standing Rock litigation continues; affects all Bakken operators, not CHRD specifically. Loss-of-DAPL scenario captured in risk factors. |
| ESG concerns / methane reporting | **No flagged controversies** | EPA methane rules apply; CHRD reports per standard E&P framework |
| Insider selling clusters | **No discretionary selling pattern** | May 1 2026 cluster is routine vesting-cycle Form 4s |

The sweep is **clean** — no item raises a meaningful red flag.

#### Evidence and Sources

XBRL income/cash flow data [S2]. FY25 10-K disclosures on impairment, reserves, NSAI [S1][S4]. Q2 2025 impairment context [S5]. Insider activity from `proxy/insider_transactions.md` [S6]. Adversarial sweep based on absence of evidence in search aggregators + no 8-K disclosures of investigations or material litigation [S7].

#### Assumption Register Updates

- **A11:** Adjusted net income FY25 ≈ $1.5-1.6B (vs. GAAP $44.5M). Estimate. High sensitivity.
- **A12:** Operating cash flow quality = high (no accruals abuse). Judgment. Medium sensitivity.

#### Tables and Calculations

##### Quality adjustments to GAAP net income

| FY | GAAP NI | + Goodwill impairment | + Acq. one-times (est) | - Bargain purchase / step-up | Adjusted NI |
|---:|---:|---:|---:|---:|---:|
| 2023 | 1,024 | 0 | 0 | 0 | ~1,024 |
| 2024 | 1,856 | 0 | 0 | ~(900) | ~900-1,000 |
| 2025 | 44.5 | +539.3 | (small hedge MtM) | 0 | ~1,500-1,600 |

##### Cash flow quality

| Metric | FY24 | FY25 | Signal |
|---|---:|---:|---|
| OpCF / Adj NI | ~2.1x | ~1.3x | normal for E&P (DD&A flows through) |
| FCF / OpCF | ~43% | ~30% | capex-heavy year (XTO close + organic) |
| Capex / DD&A | ~2.7x | ~2.4x | growth-mode (>1x = adding to asset base) |

##### Adversarial sweep — explicit "checked" list

- Searched for "CHRD short report" — no results
- Searched for "Chord Energy SEC investigation" — no results
- Searched for "Chord Energy class action" — no material results
- Reviewed Form 4 pattern for 12 months — no concerning insider sell cluster

#### Open Questions and Data Gaps

- The exact mechanics of the 2024 Enerplus purchase-price allocation (bargain purchase gain vs. asset step-up) is not parsed at line-item detail from the 10-K notes; high-level adjusted view is taken.
- 2025 Q4 standalone net income is derived from full-year minus 9-month YTD; modest precision loss.
- Some E&P-specific adjustments (ceiling test, exploration write-offs) are not separately broken out beyond what's in the press releases.

#### Next-Step Dependencies

Step 05 (quarterly momentum) will use adjusted metrics (not GAAP) for trend analysis. Step 06 (balance sheet) will reference the clean cash position and modest LT debt for solvency assessment.

#### Source Index

| Tag | Document or URL | Section | Date | Notes |
|---|---|---|---|---|
| [S1] | CHRD_financials/sec_filings/10K_FY2025_summary.md | MD&A, impairment | 2026-05-28 | Local cache |
| [S2] | CHRD_financials/xbrl/xbrl_summary.md | IS/CF tables | 2026-05-28 | Local cache |
| [S3] | CHRD_financials/other/stockanalysis_summary.md | Adjusted comparison | 2026-05-28 | Local cache |
| [S4] | CHRD_financials/sec_filings/10K_FY2025_summary.md | Reserves section | 2026-05-28 | Local cache |
| [S5] | Web search — Chord Q2 2025 goodwill impairment | $539.3M disclosure | 2025-08 | Press release |
| [S6] | CHRD_financials/proxy/insider_transactions.md | Form 4 review | 2026-05-28 | Local cache |
| [S7] | Web search aggregators (Wallstreetzen, MarketBeat, etc.) | No short reports found | 2026-05-28 | Negative evidence |

## Deeper Financial Analysis

The fundamental tier ($1.00) adds 8 dimensions not included here:

- Revenue Breakdown — segment revenue, geographic mix, product-line margins
- Financial Trends — QoQ momentum, leading indicators, inflection points
- Balance Sheet — debt structure, dilution risk, working capital dynamics
- Capital Allocation — ROIC, buyback cadence, reinvestment efficiency
- Earnings Analysis — beats/misses, guidance vs actuals, transcript highlights
- Competitive Positioning — market share, pricing power, peer benchmarks
- Industry Context — TAM, sector tailwinds/headwinds, regulatory backdrop

**API endpoint:** GET /api/v1/research/CHRD/fundamental

## Navigation

- Overview: /stocks/CHRD
- Financials (this page): /stocks/CHRD/financials
- Thesis: /stocks/CHRD/thesis
- Investment Memo: /stocks/CHRD/memo
- Coverage universe: /stocks